RUNX3 and acute myeloid leukemia: Similar effects have been observed in AML cell cultures (OCI-AML2, SKM1, and MOLM-13) treated with SIRT5 inhibitors (see compounds 8b, 8d, and 8i in Section 4.2.2) [135,136].